SCHEMBL1679244

SCHEMBL1679244

COc1ccc(C(C)C#N)cc1C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 3/20 0.42
ALDH1A1 P00352 7/20 0.41
TSHR P16473 1/20 0.41
RAB9A P51151 1/20 0.41
SLC6A2 P23975 2/20 0.40
SLC6A4 P31645 2/20 0.40
SLC6A3 Q01959 2/20 0.40
HTT P42858 2/20 0.40
ATM Q13315 1/20 0.38
FFAR1 O14842 1/20 0.38
CYP1A2 P05177 1/20 0.38
KDM4E B2RXH2 2/20 0.37
LMNA P02545 1/20 0.37
MAPT P10636 1/20 0.37
PDE4A P27815 1/20 0.37
PDE4B Q07343 1/20 0.37
PDE4C Q08493 1/20 0.37
PDE4D Q08499 1/20 0.37
AR P10275 1/20 0.36
AKR1C3 P42330 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9841161 0.85 ACHE (0.55) ACHEALDH1A1TSHRRAB9AHTT
SCHEMBL11801839 0.81 TUBB4A (0.51) ACHEALDH1A1TSHRCYP1A2KDM4E
SCHEMBL12875453 0.81 SLC6A2 (0.46) ACHEALDH1A1TSHRRAB9ASLC6A2
SCHEMBL9510754 0.81 RAB9A (0.41) ACHEALDH1A1TSHRRAB9AHTT
SCHEMBL10667940 0.81 ALDH1A1 (0.42) ACHEALDH1A1TSHRRAB9AHTT
SCHEMBL801219 0.79 HDAC4 (0.48) ACHEALDH1A1SLC6A2SLC6A4SLC6A3
SCHEMBL13304652 0.79 SLC6A2 (0.45) ACHESLC6A2SLC6A4SLC6A3FFAR1
SCHEMBL25767055 0.79 LMNA (0.39) ALDH1A1HTTCYP1A2KDM4ELMNA
SCHEMBL22477378 0.77 ALDH1A1 (0.48) ACHEALDH1A1TSHRRAB9AHTT
SCHEMBL13413339 0.77 SLC6A2 (0.44) ACHESLC6A2SLC6A4SLC6A3FFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7923573-B2 Benzene compound having 2 or more substituents DAIICHI SANKYO COMPANY, LIMITED (JP) 2011-04-12 US disclosed
US-20080004301-A1 Benzene Compound Having 2 or More Substituents DAIICHI SANKYO COMPANY, LIMITED (JP) 2008-01-03 US disclosed
EP-1806332-A1 BENZENE COMPOUND HAVING 2 OR MORE SUBSTITUENTS Daiichi Sankyo Company, Limited (JP) 2007-07-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080004301-A1 Benzene Compound Having 2 or More Substituents NR1H2, NR1H3, NCOR2 ACHE 1745/4885ALDH1A1 3512/4885TSHR 47/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.